Related Experiment Video
Updated: Jun 29, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Medication management error types: Associations with mild cognitive impairment subtype
Alyssa N De Vito1,2, Sheina Emrani3, Emily Hallowell1,4
1Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Abstract:
Objective: Medication management errors are suspected to be prevalent among older adults with mild cognitive impairment (MCI). This study examined types of simulated medication-taking errors in cognitively normal older adults (CN; n = 131), single domain amnestic MCI (sdMCI, n = 91), and multi-domain MCI (mdMCI, n = 44). Errors were measured using the medication management ability assessment (MMAA). Methods: 266 participants seen for neuropsychological evaluation (94.4% White, 57.9% female, average age = 72, average education = 14 years) completed the MMAA (version 4.1), a performance-based task of medication management. Group differences in MMAA total scores, accuracy, and error types were evaluated using Kruskall-Wallis H tests. This study was the first to explore a newly operationalized error, perseverations, caused by taking a specific dose ≥2 times during the simulation. Results: CN and sdMCI groups had higher MMAA total scores than individuals with mdMCI, indicating better overall performance. The mdMCI group made a higher number of omission errors (missed pills) than other groups, but no differences were found for commission errors (extra pills). The sdMCI group made more perseverative errors compared to the CN group. Conclusions: Individuals with mdMCI made more simulated medication management errors than CN and sdMCI groups, indicating that they may be most vulnerable to difficulties in medication management. In contrast, sdMCI individuals were more likely to make perseverative errors, which may reflect a tendency towards overcompensation of memory loss. Future studies should assess whether MMAA performance is associated with patterns of real-world medication-taking in more diverse samples of older adults.
Insights
Older adults with multi-domain mild cognitive impairment (MCI) made more medication errors. Single-domain MCI patients showed more perseverative errors, potentially overcompensating for memory loss.
Area of Science:
- Gerontology
- Neuropsychology
- Pharmacology
Background:
- Medication management errors are a significant concern for older adults, particularly those with cognitive impairments.
- Mild cognitive impairment (MCI) presents a spectrum, with varying impacts on daily functioning.
Purpose of the Study:
- To investigate and compare simulated medication-taking errors across cognitively normal (CN) older adults and those with single-domain amnestic MCI (sdMCI) and multi-domain MCI (mdMCI).
- To identify specific types of errors, including omission, commission, and perseveration, associated with different MCI subtypes.
Main Methods:
- Utilized the Medication Management Ability Assessment (MMAA) version 4.1, a performance-based task, with 266 participants (CN, sdMCI, mdMCI).
- Employed Kruskal-Wallis H tests to analyze group differences in total scores, accuracy, and error types.
- Introduced and operationalized 'perseverative errors' as taking a dose multiple times.
Main Results:
- Individuals with mdMCI demonstrated significantly lower overall performance (MMAA scores) compared to CN and sdMCI groups.
- The mdMCI group exhibited a higher frequency of omission errors (missed doses).
- The sdMCI group made more perseverative errors than the CN group, while no significant differences in commission errors were observed between groups.
Conclusions:
- Multi-domain MCI is associated with a higher vulnerability to medication management difficulties.
- Perseverative errors in sdMCI may indicate compensatory strategies for memory deficits.
- Further research is needed to correlate MMAA performance with real-world medication adherence in diverse populations.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

